90 results on '"Gill, Anthony J"'
Search Results
2. A Critical Assessment of Current Grading Schemes for Diffuse Pleural Mesothelioma With a Proposal for a Novel Mesothelioma Weighted Grading Scheme (MWGS)
3. Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors
4. Monotypic Plasma Cell Proliferation of Uncertain Clinical Significance Mimicking Interstitial Cystitis: An Early Lesion of MALT Lymphoma?
5. A Critical Assessment of Postneoadjuvant Therapy Pancreatic Cancer Regression Grading Schemes With a Proposal for a Novel Approach
6. Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers: III: Molecular Pathology of Kidney Cancer
7. Assessment of Tumor-infiltrating Lymphocytes Using International TILs Working Group (ITWG) System Is a Strong Predictor of Overall Survival in Colorectal Carcinoma: A Study of 1034 Patients
8. Precision Oncology in Surgery: Patient Selection for Operable Pancreatic Cancer
9. Head and Neck Mesenchymal Neoplasms With GLI1 Gene Alterations: A Pathologic Entity With Distinct Histologic Features and Potential for Distant Metastasis
10. Pancreatoduodenectomy With Arterial Resection for Locally Advanced Pancreatic Cancer of the Head: A Systematic Review
11. A “Double-Hit” Translocation Sarcoma—First Report of the Co-occurrence of EWSR1-FLI1 and MTMR2-NTRK2 Fusion in a Small Round Blue Cell Sarcoma
12. Morphologic Clues to Succinate Dehydrogenase (SDH) Deficiency in Pheochromocytomas and Paragangliomas
13. Evaluation of Fluorodeoxyglucose Positron Emission Tomography Scanning in the Neoadjuvant Therapy Paradigm in Pancreatic Ductal Adenocarcinoma
14. A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients
15. A Clinicopathologic and Molecular Analysis of Fumarate Hydratase-deficient Renal Cell Carcinoma in 32 Patients
16. NR4A3 Immunohistochemistry Lacks Sensitivity for the Diagnosis of Extraskeletal Myxoid Chondrosarcoma
17. SMARCA4 Loss Is Very Rare in Thoracic Mesothelioma
18. Parafibromin-deficient (HPT-JT Type, CDC73 Mutated) Parathyroid Tumors Demonstrate Distinctive Morphologic Features
19. Loss of BAP1 Expression Occurs Rarely to Never in Colorectal Adenocarcinoma
20. Reappraisal of Morphologic Differences Between Renal Medullary Carcinoma, Collecting Duct Carcinoma, and Fumarate Hydratase–deficient Renal Cell Carcinoma
21. Predicting malignancy in adrenal incidentaloma and evaluation of a novel risk stratification algorithm
22. Histopathological tumour viability after neoadjuvant chemotherapy influences survival in resected pancreatic cancer: analysis of early outcome data
23. Value of temporal artery biopsy length in diagnosing giant cell arteritis
24. The epithelioid BAP1‐negative and p16‐positive phenotype predicts prolonged survival in pleural mesothelioma
25. Succinate dehydrogenase (SDH)‐deficient neoplasia
26. Pathology and genetics of phaeochromocytoma and paraganglioma
27. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer
28. Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours
29. Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized: A Low Threshold for ALK Immunohistochemistry Is Required
30. Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC): Further Morphologic and Molecular Characterization of ESC RCC as a Distinct Entity
31. Whole-genome landscape of pancreatic neuroendocrine tumours
32. Screening for ROS1 gene rearrangements in non‐small‐cell lung cancers using immunohistochemistry with FISH confirmation is an effective method to identify this rare target
33. NRASQ61R Mutation-specific Immunohistochemistry Also Identifies the HRASQ61R Mutation in Medullary Thyroid Cancer and May Have a Role in Triaging Genetic Testing for MEN2
34. Genomic analyses identify molecular subtypes of pancreatic cancer
35. Pheo-Type: A Diagnostic Gene-expression Assay for the Classification of Pheochromocytoma and Paraganglioma
36. Needle(s) in the Haystack—Synchronous Multifocal Tumor-Induced Osteomalacia
37. Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testing
38. BRAFV600E mutation is rare in clear cell ovarian carcinoma, but could potentially be identified with mutation specific immunohistochemistry
39. Granulosa cell tumour of the adrenal
40. Efficacy of primary tumour volume as a predictor of survival compared with size alone in pancreatic ductal adenocarcinoma
41. Extended pancreatoduodenectomy as defined by the International Study Group for Pancreatic Surgery is associated with worse survival but not with increased morbidity
42. Pathogenic PALB2 mutation in metastatic pancreatic adenocarcinoma and neuroendocrine tumour: A case report
43. Loss of expression of BAP1 predicts longer survival in mesothelioma
44. The genomic landscape of phaeochromocytoma
45. Distal pancreatectomy, splenectomy, and celiac axis resection (DPS-CAR): Common hepatic arterial stump pressure should determine the need for arterial reconstruction
46. Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronism
47. Recurrent hyperaldosteronism after adrenalectomy: an indication for careful radiologic and histologic re-evaluation
48. Whole genomes redefine the mutational landscape of pancreatic cancer
49. 21. AUDIT OF PRIMARY BRAIN TUMOURS AT ROYAL NORTH SHORE HOSPITAL FROM 2007 TO 2011
50. 18. IMP3 EXPRESSION IN TRIPLE-NEGATIVE BREAST CANCER
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.